94. Clin Imaging. 2018 Mar - Apr;48:vii-xi. doi: 10.1016/j.clinimag.2017.12.016.Breast cancer screening: Where have we been and where are we going? A personalperspective based on history, data and experience.Kopans DB(1).Author information: (1)Radiology Harvard Medical School, Founder Bresat Imagning DivisionMassachusetts General Hospital, 20 Manitoba Road, Waban, MA 02468, United States.Electronic address: dkopans@partners.org.It is important to understand the history of breast cancer screening to betterunderstand the continuing effort to reduce access to screening. Since therandomized, controlled trials have shown a statistically significant mortalityreduction for women ages 40-74, the appropriate threshold for initiatingscreening is age 40 with no data to support the use of the age of 50 as athreshold for screening. All women are at risk for developing breast cancer andall women should have access to screening.Crown Copyright Â© 2018. Published by Elsevier Inc. All rights reserved.DOI: 10.1016/j.clinimag.2017.12.016 PMID: 29549915  [Indexed for MEDLINE]